Fierce Pharma

JUNE 12, 2023

Bayer recently laid out its ambition | Bayer recently laid out its ambition to achieve $10 billion in sales from its oncology business by 2030 and become a top 10 cancer drug player. To get there, the company is looking outside for a “midsize acquisition,” Bayer’s oncology chief Christine Roth said.

Sales goal 310

Sales goal Sales 310

PharmaVoice

MAY 23, 2024

Promises made by pharma and biotech companies show confidence in the future of their business and dedication to financial success, R&D and environmental protection.

Sales goal 130

Sales goal Sales Pharma 130

Spotio

FEBRUARY 9, 2023

Furthermore, the organization predicts it will outpace the GDP by 2030. This is great news for those in medtech sales! And your reps need to adopt an omnichannel process that uses all of the medical device sales channels at their disposal. Each threatens to derail your medical device sales process in some way.

Sales 52

Sales Medical Doctors Sales process 52

Fierce Pharma

OCTOBER 31, 2024

While Merck's oncology powerhouse Keytruda delivered another multibillion-dollar sales haul in the third quarter, regional fright surrounding another staple product took the spotlight during the co | Despite the China growth woes, Merck is still confident it can achieve its $11 billion sales goal for the HPV vaccine by 2030.

Sales goal 263

Sales goal Sales 263